Categories
BLOG

inbred strains

Inbred strains

The laboratory mouse is the primary model organism for the study of human biology and disease. An inbred strain of mice represents a unique fixed genotype that can be accessed repeatedly as individual yet homogeneous experimental subjects with a predictable phenotype and defined allelic complement. Hundreds of inbred strains of mice have been described and new strains continue to be developed, taking advantage of the rich genetic diversity among the existing strains and the ease with which the mouse genome can be manipulated.

The genealogy chart of inbred strains graphically depicts the origins and relationships of inbred mouse strains.

Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, Festing MFW, Fisher EMC. 2000. Genealogies of mouse inbred strains. Nature Genetics 24: 23-25. J:59229 PubMed

The chart is available as a downloadable Portable Document Format (PDF) file (file size: 4398 Kbytes).

  • You can download the Adobe Acrobat Reader (free) to view or print this PDF file.
  • Contact your system administrator if you have memory allocation or browser issues.

Accompanying the chart is a Key to the Chart of Strain Genealogies providing, for each strain on the Chart, location coordinates, a reference to its genealogy, and an indication whether it was extant when the chart was generated.

These files are available through the courtesy of Nature Genetics. In the future, the chart and its data will be incorporated into the Mouse Genome Database (MGD), where fuller historical tracking can be documented and the chart continuously updated and expanded.

Additional information on Inbred Strains is available at Strains, SNPs and Polymorphisms.

Inbred strains The laboratory mouse is the primary model organism for the study of human biology and disease. An inbred strain of mice represents a unique fixed genotype that can be accessed

Center for Mouse Genome Modification

Source: Mouse Genome Informatics email list.

Question

We recently found a treatment that protected B6 (inbred) mice against hypoxia. When we tested the same treatment with ICR (outbred) mice, however, we obtained largely scattered results. Some ICR mice were already relatively resistant to hypoxia without the treatment, while others were still vulnerable even with the treatment. With my limited knowledge in genetics, I understand that the ICR results are more or less expected because of diversity in gene functions in individual outbred mice (could anyone expand on this topic in terms of mouse genetics?). But don’t we human beings resemble ICR more than B6? Does the thirst for “clinical relevance” diminish the significance of our finding in B6? Any advice would be appreciated.

Answer

I can reply to your question from the perspective of someone using animal models in drug development.

You’ve fallen into what has been a long-running debate in drug development circles. An individual investigator’s preference likely depends on what point in the drug development process they are involved, from target validation to preclincal disease models to toxicology. The further downstream, the more interest there often is in outbred animals.

You are correct in saying that one of the perceived advantages of using outbred strains is that they supposedly more accurately mimic what one would find in humans. From the perspective of drug development, this would make it more likely that one could find evidence of genotype-dependent toxicity (a common reason for a drug to fail, so something one would want to find evidence of as soon as possible), as well as facilitate the identification of biomarkers that could prove useful or pharmacogenomics or to initiate a hunt for new targets through mapping QTLs. Incidentally, such heterogeneity in humans is likely explains at least in part why most drugs only work in

30% of patients, which is why there is so much interest in identifying markers that can place patients into responding and non-responding groups.

The disadvantage of outbred strains, as you have discovered, it that one’s results may be much more irreproducible. And depending on the strength of the effect, you may miss it entirely (of course, the same can happen if you choose the wrong inbred strain for your studies). Increased numbers of animal are often required to overcome this.

An additional factoid to consider is that it has generally been under-appreciated just how inbred most outbred strains actually are. I recently heard Howard Jacob (Medical College of Wisconsin) give a talk in which he showed that in Sprague Dawley rats

one-third of the genome was fully inbred, and the average number of alleles for most loci was only 2(whereas in a panel of 48 different inbred strains, the total available diversity averaged around 6 alleles/locus). Based on this, he has come up with a combinatorial intercrossing strategy between 4 strains that results in greater diversity.

As someone who works in target validation (using animal models to show that a particular drug target is likely to affect a disease of interest, so as to justify further downstream development), it is my bias that inbred models are the best way to go. The mouse is clearly a reasonable, but far from perfect model of human disease. As they say, it is easy to cure a mouse of cancer, but a lot of those therapies don’t end up working in humans. Given this, I’d much rather be able to rapidly obtain reproducible results in the mouse, and then go on and do the real experiment in humans. Focusing on genetic diversity in a mouse model of disease may be putting the cart before the horse in many cases.

Bottom line: if we had your results, we would ignore the outbred model and use the positive results in the inbred model to justify further drug development work. I’m certain most companies would do the same.

-Kevin P. Foley (Millennium Pharmaceuticals, Inc.)

References
Banbury Conference on Genetic Background in Mice (1997). Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 19, 755-759.

Source: Mouse Genome Informatics email list.QuestionWe recently found a treatment that protected B6 (inbred) mice against hypoxia. When we tested the same treatment with ICR (outbred) mice, however, we obtained largely scattered results. Some ICR mice were already relatively resistant to hypoxia …